No abstract available.
Breast Neoplasms* ; Breast* ; Survival Rate*

Restriction enzyme-mediated integration (REMI) was used to transform uracil auxotrophs of Pleurotus ostreatus to prototrophy. When protoplasts of Pleurotus ostreatus were treated by the reaction mixture containing 10 units of BamHI, the frequency of REMI was about 64 transformants per 1 microg of DNA. This efficiency was increased by 14.2 times compared with that of the conventional PEG transformation. The optimal condition for REMI of P. ostreatus was achieved when 1 microg of linearized pTRura3-2 DNA was added into 1x10(7) protoplasts along with 10 units BamHI. Southern blot analysis revealed that about 50% of transformants examined were caused by REMI event and 30% carried single copy insertion at the genome. This suggested that the REMI method might be a useful tool for efficient transformation and tagging mutagenesis of P. ostreatus.
Blotting, Southern ; DNA ; Genome ; Mutagenesis ; Pleurotus* ; Protoplasts ; Uracil

PURPOSE: To assess the effect of hydration status on renal medullary attenuation and to evaluate the incidence of dense renal medulla, as seen on unenhanced CT. MATERIAL AND METHODS: We prospectively studiedunenhanced CT scans of 12 healthy volunteers. Obtained done after 10 hours and 15 hours of dehydration and afteroral intake of 2L of water. BUN/Cr, urine specific gravity, urine osmole and hematocrit were evaluated after 10hours of dehydration. CT images were reviewed for the presence of dense renal medulla and differential attenuationof dense renal and isodense medulla and cortex at the same level. The density changes of renal medulla afterhydration were evaluated. and CT findings were compared with the results of biochemical studies. In addition, weretrospectively reviewed the CT scans of 200 consecutive patients for evaluation of the incidence of dense renalmedulla. RESULTS: In 8 of 12 volunteers, dense renal medulla was seen on CT scan after dehydration. Meanattenuation was 71.3 +/-10.42HU after 10 hours of dehydration, 68.6 +/-13.54HU after 15 hours, and 34.5 +/-11.47HUafter hydration. No significant attenuation differences were detected between 10 hours and 15 hours ofdehydration, but significantly lower attenuation values were noted after hydration. For isodense medulla, the meanattenuation value was 35.7 +/-7.9HU after 10 hours of dehydration, 39.58 +/-9.66HU after 15 hours, and 36.58+/-7.77HU after hydration. The mean attenuation values of cortex were 35.9 +/-5 . 9 5 H U after 10 hours ofdehydration, 37.58 +/-5.95HU after 15 hours, and 37.08 +/-9.75HU after hydration. With regard not only to durationof dehydration, but also ti hydration, no differences in attenuation values were noted for renal cortex orisodense renal medulla. However, higher density was noted in dense renal medulla than in isodense medulla orcortex for the same duration of dehydration. After hydration, complete resolution was seen at five of eight sitesand incomplete resolution at three of eight sites. There was no correlation between CT attenuation and laboratoryresults. Dense renal medulla was seen in 17 of 200 consecutive patients. Mean attenuation values were 64.06+/-8.38HU for dense renal medulla, 37.15 +/-8 . 4 4 H U for isodense renal medulla and 35.36 +/-8.13HU for cortex. CONCLUSION: For the same duration of dehydration, dense renal medulla showed a higher attenuation value thanisodense medulla or cortex, a finding which was completely or incompletely resolved after hydration. Inconsecutive patients, the incidence of dense renal medulla was 8.5% In conclusion, this in-cidence is aphysiological, variable, reflecting dehydration status.
Dehydration ; Healthy Volunteers ; Hematocrit ; Humans ; Incidence ; Prospective Studies ; Specific Gravity ; Tomography, X-Ray Computed ; Volunteers ; Water

BACKGROUND: Prophylactic stenosis correction is important in the durability of the vascular access, and routine surveillance for the detection of stenosis has been widely recommended to allow preemptive intervention before thrombotic occlusion. The ultrasound dilution technique has been considering not only a popular and validated in vascular access surveillance, but also useful in the measurement of access recirculation and cardiac output. METHODS: Access flow, recirculation, and cardiac output of seventy-six hemodialysis patients with arteriovenous fistulae were measured by ultrasound dilution technique, followed by access flow measurement by color doppler ultrasound in sixty-four patients. Access stenosis was defined as 50% and more reduction in the diameter of vessels by color doppler ultrasound. Cardiac output of thirty-seven patients by echocardiography within a year was also analyzed. RESULTS: Access stenosis was diagnosed in six of sixty-four patients by color doppler ultrasound (9.4%). Access flow in the group with stenosis (621+/-322 mL/min) was lower than the group without stenosis (1, 005+/-633 mL/min), but no statistical significance was found. The access flow measured by ultrasound dilution technique was significantly correlated with color doppler ultrasound (r=0.436, p= 0.01). The cardiac output measured by ultrasound dilution technique was also significantly correlated with echocardiography (r=0.660, p=0.01). CONCLUSION: The data did not provide statistical significances for the detection of stenosis by ultrasound dilution technique. But this study suggests that ultrasound dilution technique is a useful method in the measurement of access flow, cardiac output and recirculation. We hope further prospective studies based on our data will be performed.
Arteriovenous Fistula ; Cardiac Output ; Constriction, Pathologic ; Echocardiography ; Hope ; Humans ; Indicator Dilution Techniques ; Renal Dialysis* ; Ultrasonography*

Protoplasts of the wild type strain of Pleurotus osteatus were mutagenized with UV light, and 3,000 colonies were examined for abnormal mycelial and fruiting phenotypes. Forty one strains displayed variant phenotypes in mycelia and fruiting processes. The variant phenotypes were classified into 6 groups: (1) auxotrophic strains, which are incapable of growing on minimal media and can only grow when provided with their specific requirements; (2) abnormal vegetative strains, which grow very slowly on minimal and complete media; (3) primordiumless strains, which fail to develop to the formation of primordia; (4) maturationless strains, which form primordia, but do not form mature fruiting bodies; (5) specifically colored strains, which have Specific bluish grey or bluish white pileus; (6) poorly spored strains, which fail to produce basidiospore or which produce few spores. These variant strains may be useful in genetic breeding programs and for the studies of fungal development and genetics.
Breeding ; Fruit ; Genetics ; Phenotype ; Pleurotus* ; Protoplasts ; Spores ; Ultraviolet Rays

Background: The risk of device thrombosis and device-oriented clinical outcomes with bioresorbable vascular scaffold (BVS) was reported to be significantly higher than with contemporary drug-eluting stents (DESs). However, optimal device implantation may improve clinical outcomes in patients receiving BVS. The current study evaluated mid-term safety and efficacy of Absorb BVS with meticulous device optimization under intravascular imaging guidance. Methods: The SMART-REWARD and PERSPECTIVE-PCI registries in Korea prospectively enrolled 390 patients with BVS and 675 patients with DES, respectively. The primary endpoint was target vessel failure (TVF) at 2 years and the secondary major endpoint was patientoriented composite outcome (POCO) at 2 years. Results: Patient-level pooled analysis evaluated 1,003 patients (377 patients with BVS and 626 patients with DES). Mean scaffold diameter per lesion was 3.24 ± 0.30 mm in BVS group.Most BVSs were implanted with pre-dilatation (90.9%), intravascular imaging guidance (74.9%), and post-dilatation (73.1%) at proximal to mid segment (81.9%) in target vessel.Patients treated with BVS showed comparable risks of 2-year TVF (2.9% vs. 3.7%, adjusted hazard ratio [HR], 1.283, 95% confidence interval [CI], 0.487–3.378, P = 0.615) and 2-year POCO (4.5% vs. 5.9%, adjusted HR, 1.413, 95% CI, 0.663–3.012,P = 0.370) than those with DES. The rate of 2-year definite or probable device thrombosis (0.3% vs. 0.5%, P = 0.424) was also similar. The sensitivity analyses consistently showed comparable risk of TVF and POCO between the 2 groups. Conclusion With meticulous device optimization under imaging guidance and avoidance of implantation in small vessels, BVS showed comparable risks of 2-year TVF and device thrombosis with DES.